Samyang Holdings decides to merge with Samyang BioPharm

[Infostock Daily=Reporter Lee Ji-sun] Samyang Holdings announced on the 27th that it will absorb and merge Samyang BioPharm, a subsidiary specializing in the pharmaceutical bio business.

Samyang Holdings plans to complete the merger on April 1 through related procedures.

Through this merger, Samyang Holdings plans to promote mid- to long-term corporate value by leading the pharmaceutical bio business.

Samyang Biopharm expects that it will be able to secure funds for planned mid- to long-term investments in the future, including the development of new drugs and new global businesses, and increase its global credibility to accelerate its tap into the global market.

Reporter Lee Ji-sun stockmk2020@gmail.com